154 related articles for article (PubMed ID: 36609301)
21. Validation of 7th TNM staging system for lung cancer, based on surgical outcomes.
Yoshida Y; Murayama T; Sato Y; Suzuki Y; Saito H; Tanaka N
Asian Cardiovasc Thorac Ann; 2013 Dec; 21(6):693-9. PubMed ID: 24569328
[TBL] [Abstract][Full Text] [Related]
22. Validation of the lung cancer staging system revisions using a large prospective clinical trial database (ACOSOG Z0030).
Fibla JJ; Cassivi SD; Decker PA; Allen MS; Darling GE; Landreneau RJ; McKenna RJ; Putnam JB;
Eur J Cardiothorac Surg; 2013 May; 43(5):911-4. PubMed ID: 23014970
[TBL] [Abstract][Full Text] [Related]
23. Including positive lymph node count in the AJCC N staging may be a better predictor of the prognosis of NSCLC patients, especially stage III patients: a large population-based study.
Fan Y; Du Y; Sun W; Wang H
Int J Clin Oncol; 2019 Nov; 24(11):1359-1366. PubMed ID: 31183778
[TBL] [Abstract][Full Text] [Related]
24. [Application of the 2007 lung cancer staging system by International Association for the Study of Lung Cancer].
Wang J; Wu N; Zheng QF; Feng Y; Yan S; Yang Y
Beijing Da Xue Xue Bao Yi Xue Ban; 2009 Aug; 41(4):442-6. PubMed ID: 19727235
[TBL] [Abstract][Full Text] [Related]
25. [Validity and controversies in the new postoperative pathologic TNM classification based on the results of surgical treatment of non-small cell lung cancer].
Hosokawa Y; Matsuge S; Murakami Y; Satoh K; Yamazaki S; Kan T; Hatakeyama H
Kyobu Geka; 2000 Oct; 53(11):910-4. PubMed ID: 11048440
[TBL] [Abstract][Full Text] [Related]
26. Upstaging by vessel invasion improves the pathology staging system of non-small cell lung cancer.
Tsuchiya T; Hashizume S; Akamine S; Muraoka M; Honda S; Tsuji K; Urabe S; Hayashi T; Yamasaki N; Nagayasu T
Chest; 2007 Jul; 132(1):170-7. PubMed ID: 17505030
[TBL] [Abstract][Full Text] [Related]
27. Prognostic Effect of Lymphovascular Invasion on TNM Staging in Stage I Non-Small-cell Lung Cancer.
Noma D; Inamura K; Matsuura Y; Hirata Y; Nakajima T; Yamazaki H; Hirai Y; Ichinose J; Nakao M; Ninomiya H; Mun M; Nakagawa K; Masuda M; Ishikawa Y; Okumura S
Clin Lung Cancer; 2018 Jan; 19(1):e109-e122. PubMed ID: 29066222
[TBL] [Abstract][Full Text] [Related]
28. Prognostic value of the 2002 TNM classification for breast carcinoma with regard to the number of metastatic axillary lymph nodes.
Duraker N; Caynak ZC
Cancer; 2005 Aug; 104(4):700-7. PubMed ID: 16003773
[TBL] [Abstract][Full Text] [Related]
29. Poor prognostic factors in patients with stage IB non-small cell lung cancer according to the seventh edition TNM classification.
Maeda R; Yoshida J; Ishii G; Hishida T; Nishimura M; Nagai K
Chest; 2011 Apr; 139(4):855-861. PubMed ID: 20724736
[TBL] [Abstract][Full Text] [Related]
30. Validation of the prognostic value of new sub-stages within the AJCC 8th edition of non-small cell lung cancer.
Abdel-Rahman O
Clin Transl Oncol; 2017 Nov; 19(11):1414-1420. PubMed ID: 28497423
[TBL] [Abstract][Full Text] [Related]
31. Prognostic assessment of 2,361 patients who underwent pulmonary resection for non-small cell lung cancer, stage I, II, and IIIA.
van Rens MT; de la Rivière AB; Elbers HR; van Den Bosch JM
Chest; 2000 Feb; 117(2):374-9. PubMed ID: 10669677
[TBL] [Abstract][Full Text] [Related]
32. Metabolic tumor burden quantified on [
Lapa P; Oliveiros B; Marques M; Isidoro J; Alves FC; Costa JMN; Costa G; de Lima JP
Eur J Nucl Med Mol Imaging; 2017 Dec; 44(13):2169-2178. PubMed ID: 28785842
[TBL] [Abstract][Full Text] [Related]
33. Comparison of clinical and pathological tumor, node and metastasis staging of lung cancer: 15-year experience with 530 patients.
Turk F; Gursoy S; Yaldiz S; Yuncu G; Yazgan S; Basok O
Minerva Chir; 2011 Dec; 66(6):509-16. PubMed ID: 22233657
[TBL] [Abstract][Full Text] [Related]
34. Validation of the Stage Groupings in the Eighth Edition of the TNM Classification for Lung Cancer.
Sui X; Jiang W; Chen H; Yang F; Wang J; Wang Q
J Thorac Oncol; 2017 Nov; 12(11):1679-1686. PubMed ID: 28782726
[TBL] [Abstract][Full Text] [Related]
35. External Validation of a Survival Nomogram for Non-Small Cell Lung Cancer Using the National Cancer Database.
Young KA; Efiong E; Dove JT; Blansfield JA; Hunsinger MA; Wild JL; Shabahang MM; Facktor MA
Ann Surg Oncol; 2017 Jun; 24(6):1459-1464. PubMed ID: 28168388
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of the new TNM staging system proposed by the International Association for the Study of Lung Cancer at a single institution.
Kameyama K; Takahashi M; Ohata K; Igai H; Yamashina A; Matsuoka T; Nakagawa T; Okumura N
J Thorac Cardiovasc Surg; 2009 May; 137(5):1180-4. PubMed ID: 19379988
[TBL] [Abstract][Full Text] [Related]
37. Prognosis of 6644 resected non-small cell lung cancers in Japan: a Japanese lung cancer registry study.
Goya T; Asamura H; Yoshimura H; Kato H; Shimokata K; Tsuchiya R; Sohara Y; Miya T; Miyaoka E;
Lung Cancer; 2005 Nov; 50(2):227-34. PubMed ID: 16061304
[TBL] [Abstract][Full Text] [Related]
38. Predicting Lung Cancer Survival Using Probabilistic Reclassification of TNM Editions With a Bayesian Network.
Sieswerda MS; Bermejo I; Geleijnse G; Aarts MJ; Lemmens VEPP; De Ruysscher D; Dekker ALAJ; Verbeek XAAM
JCO Clin Cancer Inform; 2020 May; 4():436-443. PubMed ID: 32392098
[TBL] [Abstract][Full Text] [Related]
39. Validation of the 8th TNM classification for small-cell lung cancer in a retrospective material from Sweden.
Tendler S; Grozman V; Lewensohn R; Tsakonas G; Viktorsson K; De Petris L
Lung Cancer; 2018 Jun; 120():75-81. PubMed ID: 29748020
[TBL] [Abstract][Full Text] [Related]
40. Developing and validating an integrated gross tumor volume (GTV)-TNM stratification system for supplementing unresectable locally advanced non-small cell lung cancer treated with concurrent chemoradiotherapy.
Chen NB; Li QW; Zhu ZF; Wang YM; Cheng ZJ; Hui ZG; Guo SP; He HQ; Wang B; Huang XY; Li JB; Guo JY; Hu N; Ai XL; Zhou Y; Wang DQ; Liu FJ; Xie CM; Qiu B; Liu H
Radiat Oncol; 2020 Nov; 15(1):260. PubMed ID: 33168045
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
